vTv Therapeutics (VTVT) Accounts Payables (2016 - 2025)
Historic Accounts Payables for vTv Therapeutics (VTVT) over the last 12 years, with Q3 2025 value amounting to $9.8 million.
- vTv Therapeutics' Accounts Payables rose 5745.26% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 5745.26%. This contributed to the annual value of $5.0 million for FY2024, which is 5091.78% down from last year.
- vTv Therapeutics' Accounts Payables amounted to $9.8 million in Q3 2025, which was up 5745.26% from $5.2 million recorded in Q2 2025.
- vTv Therapeutics' 5-year Accounts Payables high stood at $12.5 million for Q1 2022, and its period low was $4.2 million during Q1 2025.
- Moreover, its 5-year median value for Accounts Payables was $7.3 million (2022), whereas its average is $7.5 million.
- Per our database at Business Quant, vTv Therapeutics' Accounts Payables surged by 15123.87% in 2022 and then plummeted by 5199.86% in 2025.
- vTv Therapeutics' Accounts Payables (Quarter) stood at $8.0 million in 2021, then dropped by 8.85% to $7.3 million in 2022, then skyrocketed by 40.05% to $10.2 million in 2023, then plummeted by 50.92% to $5.0 million in 2024, then surged by 95.01% to $9.8 million in 2025.
- Its last three reported values are $9.8 million in Q3 2025, $5.2 million for Q2 2025, and $4.2 million during Q1 2025.